WT
RYTM icon

Whittier Trust’s Rhythm Pharmaceuticals RYTM Stock Holding History

Whittier Trust’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$157K Hold
1,811
– – ﹤0.01% 634
2025
Q4 		$180K Hold
1,811
– – ﹤0.01% 617
2025
Q3 		$179K Buy
1,811
+51
+3% +$4.74K ﹤0.01% 607
2025
Q2 		$111K Hold
1,760
– – ﹤0.01% 770
2025
Q1 		$93.2K Hold
1,760
– – ﹤0.01% 799
2024
Q4 		$98.5K Sell
1,760
-240
-12% -$13.3K ﹤0.01% 794
2024
Q3 		$105K Hold
2,000
– – ﹤0.01% 783
2024
Q2 		$82.1K Hold
2,000
– – ﹤0.01% 812
2024
Q1 		$86.6K Hold
2,000
– – ﹤0.01% 815
2023
Q4 		$91.9K Buy
+2,000
New +$63.1K ﹤0.01% 786

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Whittier Trust's RYTM Position: Q1 2026 in Review

Whittier Trust held its Rhythm Pharmaceuticals (RYTM) position steady in Q1 2026 at 1,811 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #634.

Whittier Trust first reported a position in RYTM in Q4 2023 and has held it in 10 quarters since. The position peaked at $180K in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Whittier Trust held 1,811 shares of Rhythm Pharmaceuticals worth $157K as of Q1 2026.
  • Whittier Trust left its Rhythm Pharmaceuticals share count unchanged in Q1 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Whittier Trust's portfolio in Q1 2026, its #634 holding.
  • Whittier Trust first reported a position in Rhythm Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Whittier Trust's Rhythm Pharmaceuticals position peaked at $180K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.